metformin has been researched along with Breast Cancer, Male in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pre-diagnostic use of metformin and TTh were, independently and jointly, inversely associated with incident prostate and colorectal cancers." | 4.12 | Metformin and testosterone replacement therapy inversely associated with hormone-associated cancers (prostate, colorectal and male breast cancers) among older White and Black men. ( Alzweri, L; Baillargeon, J; Canfield, S; Kristen Peek, M; Kuo, YF; Lopez, DS; Malagaris, I; Milani, SA; Polychronopoulou, E; Tsilidis, KK; Villasante-Tezanos, A, 2022) |
| "HER2-positive breast tumors are found in 25-30% of patients with breast cancer and are characterized by aggressive course and reduced sensitivity to both chemotherapy and hormone therapy." | 1.51 | Enchancement of Toremifene Anti-Tumor Action by Metformin and Unusual Side Effect of Toremifene in Male Transgenic Mice with HER2-Positive Breast Tumor. ( Alexandrov, VA; Baranenko, DA; Bespalov, VG; Filatova, LV; Osipov, MA; Panchenko, AV; Semenov, AL; Semiglazova, TY; Stukov, AN; Tyndyk, ML; Yurova, MN, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lopez, DS | 1 |
| Malagaris, I | 1 |
| Polychronopoulou, E | 1 |
| Tsilidis, KK | 1 |
| Milani, SA | 1 |
| Kristen Peek, M | 1 |
| Villasante-Tezanos, A | 1 |
| Alzweri, L | 1 |
| Baillargeon, J | 1 |
| Kuo, YF | 1 |
| Canfield, S | 1 |
| Stukov, AN | 1 |
| Osipov, MA | 1 |
| Semiglazova, TY | 1 |
| Filatova, LV | 1 |
| Alexandrov, VA | 1 |
| Bespalov, VG | 1 |
| Semenov, AL | 1 |
| Tyndyk, ML | 1 |
| Yurova, MN | 1 |
| Panchenko, AV | 1 |
| Baranenko, DA | 1 |
2 other studies available for metformin and Breast Cancer, Male
| Article | Year |
|---|---|
Metformin and testosterone replacement therapy inversely associated with hormone-associated cancers (prostate, colorectal and male breast cancers) among older White and Black men.
Topics: Aged; Breast Neoplasms, Male; Colorectal Neoplasms; Humans; Male; Medicare; Metformin; Prostate; Pro | 2022 |
Enchancement of Toremifene Anti-Tumor Action by Metformin and Unusual Side Effect of Toremifene in Male Transgenic Mice with HER2-Positive Breast Tumor.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Breast Neoplasms, Male; Disease Models, Animal; Fe | 2019 |